Answers are grounded in this paper and cite their sources.
Cohort analysis reveals rare HBV reactivation events after HBsAg seroclearance, suggesting need for ongoing monitoring.
Reactivation-related events after HBsAg seroclearance were rare in this population-based cohort. These findings suggest that HBsAg seroclearance may not necessarily indicate complete viral eradication and that careful long-term monitoring may be warranted, particularly in patients with advanced liver disease.
No takes yet. Share an insight, caveat, or question.
Yamasaki et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: